$673.69
0.10% yesterday
NYSE, Apr 01, 10:10 pm CET
ISIN
US58155Q1031
Symbol
MCK

McKesson Stock price

$673.69
+29.16 4.52% 1M
+175.21 35.15% 6M
+103.78 18.21% YTD
+137.20 25.57% 1Y
+366.69 119.44% 3Y
+540.63 406.31% 5Y
+450.98 202.50% 10Y
NYSE, Closing price Tue, Apr 01 2025
+0.70 0.10%
ISIN
US58155Q1031
Symbol
MCK
Sector

Key metrics

Market capitalization $84.43b
Enterprise Value $93.29b
P/E (TTM) P/E ratio 30.88
EV/FCF (TTM) EV/FCF 48.38
EV/Sales (TTM) EV/Sales 0.27
P/S ratio (TTM) P/S ratio 0.25
P/B ratio (TTM) P/B ratio negative
Dividend yield 0.41%
Last dividend (FY25) $2.75
Revenue growth (TTM) Revenue growth 14.29%
Revenue (TTM) Revenue $344.58b
EBIT (operating result TTM) EBIT $4.47b
Free Cash Flow (TTM) Free Cash Flow $1.93b
Cash position $1.28b
EPS (TTM) EPS $21.82
P/E forward 25.21
P/S forward 0.23
EV/Sales forward 0.26
Short interest 1.67%
Show more

Is McKesson a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,804 stocks worldwide.

McKesson Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a McKesson forecast:

15x Buy
79%
3x Hold
16%
1x Sell
5%

Analyst Opinions

19 Analysts have issued a McKesson forecast:

Buy
79%
Hold
16%
Sell
5%

Financial data from McKesson

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
344,583 344,583
14% 14%
100%
- Direct Costs 331,798 331,798
14% 14%
96%
12,785 12,785
9% 9%
4%
- Selling and Administrative Expenses 7,675 7,675
4% 4%
2%
- Research and Development Expense - -
-
-
5,110 5,110
17% 17%
1%
- Depreciation and Amortization 645 645
8% 8%
0%
EBIT (Operating Income) EBIT 4,465 4,465
22% 22%
1%
Net Profit 2,826 2,826
6% 6%
1%

In millions USD.

Don't miss a Thing! We will send you all news about McKesson directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

McKesson Stock News

Neutral
Seeking Alpha
8 days ago
I maintain a 'Strong Buy' rating on McKesson with a fair value of $723 per share due to its robust oncology network and strong growth prospects. McKesson's minimal exposure to US-Mexico-Canada tariffs and geopolitical tensions ensures stability, making it a reliable investment amid economic uncertainties. The company's GLP-1 and oncology franchises are key growth drivers, with GLP-1 revenue gro...
Positive
24/7 Wall Street
11 days ago
Investing in dividend growth stocks is a smart, reliable way to build passive income that lasts a lifetime, and it's worth considering if you're eyeing financial freedom.
Negative
MarketBeat
23 days ago
As of early March 2025, investors—and consumers—have once again begun to feel skittish about the possibility of an impending recession. At least two major factors have contributed most recently to this sentiment: first, a dreaded inverted yield curve in the final days of February, and second, the Atlanta Fed's model to predict GDP growth for the first quarter of the year was revised down to -2....
More McKesson News

Company Profile

McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. It operates through the following segments: U.S. Pharmaceutical and Specialty Solutions; European Pharmaceutical Solutions; Medical-Surgical Solutions and Other. The U.S. Pharmaceutical and Specialty Solutions segment distributes pharmaceutical and other healthcare-related products and also provides pharmaceutical solutions to pharmaceutical manufacturers in the United States. The European Pharmaceutical Solutions segment provides distribution and services to wholesale, institutional and retail customers and serves patients and consumers in 13 European countries. The Medical-Surgical Solutions segment focuses on medical-surgical supplies and provides logistics and other services to healthcare providers in the United States. The Other segment comprises on McKesson Canada, McKesson Prescription Technology Solutions and in a joint venture. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.

Head office United States
CEO Brian Tyler
Employees 51,000
Founded 1833
Website www.mckesson.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today